A2Z, I'll make a quick end of day summary below as concise as possible ok my friend.
1. TSOI has already proven capable of securing Private Placement Restricted 144 Share financing from accredited investors which most OTC PubCo's never achieve.
2. TSOI provides the utmost in transparency one could ever dream of receiving on any OTC PubCo ok! Whether it's the fact that they're a full SEC Registered/Reporting Company, the fully audited PCAOB financials, the fact they're subscribed to OTC Markets green shield direct from the transfer agent share structure program, the factual FDA PR's that speak for themselves, and the TSOI CEO shareholder educational forum...where our scientist CEO has never once dodged a single question from anyone, nor has he ever once taken any balls presented to him and ran with them like 99% of other OTC CEO's do.
3. TSOI's JadiCell IP solution provides 4 separate novel one-of-a-kind curing solutions humanity desperately needs. But the main 1st side of all that their JadiCell IP alone does relates to covid ok. So that's why I have been so laser focused on what TSOI themselves already informed the market 4 weeks ago ie: They're actively engaged in partnership discussions identifying the optimal big pharma partner on the Covid side of what their novel JadiCell IP solution factually does, as already proven in spades by the FDA Phase I studies and Phase 2 clinical trials themselves ok!
4. TSOI has also already informed the market that although they totally qualify for the new Biden admins covid grants...they've already realized that they definitely don't have time to wait along with the 10's of thousands of other American Companies that qualify for covid grant monies...so they've already informed the market that they've moved on from wasting the time it would take to get Covid grant monies from Uncle Sam they more than factually qualify for.
5. So the long & short of this exact/precise juncture is really quite simple ok. TSOI has already proven more than capable of raising the most favorable financing any OTC PubCo can secure in the form of Private Placement financing from accredited investors...and TSOI has also already informed the market that they're actively engaged in real time behind the scenes discussions with optimal big pharma collaborative partners with the global infrastructure already in place to sign/secure exclusive licensing deals to be TSOI's covid side of JadiCell collaborative partner of choice! And with such a career established All Star cast of TSOI executives already assembled here...many of which serve on the boards of multiple big board biotech sector stocks...it's not even guesswork whatsoever that this All Star team of executives have more than likely already identified the optimal big pharma partner for the novel covid one-of-a-kind JadiCell solutions humanity so desperately needs ok.
6. So to quickly summarize all of the above quick handful of points, all one has to do is review all the due diligence on just their novel JadiCell IP solution alone...including the FDA's specific request made to TSOI for them to move forward on the novel CTE side their JadiCell IP also brings solutions that humanity desperately needs. But the biggest tell of all 5 points above for me is this ok; that being that TSOI has also already informed the market that their entire executive management roster and scientific advisory board already assembled here is planning on filing EUA's on their novel covid side of their one-of-a-kind JadiCell solution humanity desperately needs as fast as humanly and practically possible ok! So by extension...by all of us simply applying the most practical common sense to TSOI's ever-evolving/emerging Covid JadiCell growth equation...we already know that it would make the most sense for TSOI to 1st secure the optimal/perfect big pharma collaborative partner to pay for the Phase III human clinical tials, while simultaneously applying for multiple EUA's all around the globe ok! I'm not saying that's exactly what's going to happen of course...but that's certainly what a big pharma collaborative partner would most definitely 100% do in a heartbeat if TSOI's All Star team of career distinguished executives simply granted the optimal big pharma collaborative partner an exclusive licensing deal ok. So in a nutshell we already have the entire FACTUAL bread crumb trail already laid out for us...by simply reading every single FACTUAL thing TSOI's entire All Star team of assembled executives has already informed the market is coming.
So to summarize the half dozen points above as follows the fastest way I can here we go ok:
1. TSOI's definitely not wasting time getting stuck in the incredible covid grant monies backlog queue even though they fully qualify for monies from Uncle Sam
2. TSOI's already factually proven quite capable of securing Private Placement financing from accredited investors
3. The right/optimal big pharma partner would pay the full $20M approx Phase III JadiCell human clinical trials in a heartbeat for TSOI simply granting them exclusive licensing deals
4. So when our scientist CEO and this FACTUAL All Star team of career executives tells us that none of us have to worry about dilution...we already know that absolutely none of them would remotely say it, when all of them wouldn't remotely be here in the 1st place unless they didn't all already know that TSOI was going to further enhance their already distinguished(and in some cases world renowned) biotech sector careers ok!
5. And for all any of us joe retail core shareholder investors know...TSOI's factual All Star team of already career established executives have already identified and verbally agreed with securing the optimal big pharma covid side of JadiCell collaborative partner. The TSOI executives, the big pharma collaborative partner and all us joe retailers already vested here are now all simply waiting for the red tape involved to get fully vetted and fully signed off. Because any global deals of magnitude definitely do take a ton of FACTUAL red tape...but luckily for us, TSOI is a full Registered/Reporting SEC Company. Which means the optimal big pharma collaborative partner already has PCAOB audited financials to rely on as their side of the partnership deal completes their normal vetting/due diligence process b4 officially signing off on any global exclusive licensing deals ok!
That's just me totally ending the day with some quick and easy thoughts in common sense layman's terms ok my friend. But just remember...the Phase II FDA clinical trial JadiCell FACTS already unveiled do ALL the factual talking necessary as to just how valuable their JadiCell IP alone is...without even remotely taking into account how many of TSOI's additional 53 IP's already filed and counting, have already passed through the FDA Phase I studies and Phase II clinical trials. And TSOI's assembled executive dream team roster has also already informed the market that they plan on filing up to another 100 IP's ok! So when I say we've stumbled across one of the best ever biotech foundations I've personally ever encountered in my entire OTC playing career...I'm not remotely joking! Just like our scientist CEO Tim Dixon wasn't remotely joking when he flat out stated that just their JadiCell IP alone easily represents a $500B valuation alone, on a truly global scale/basis ok.
Are all us joe retailers here ahead of big boy boutique investment firm money? You're darn right we are! But guess how fast that changes the exact/precise moment the big pharma JadiCell collaborative partner unveils themselves to the world? This isn't some maybe story...the FDA's own Clinical Phase II trial results speak all the mind blowing FACTS any of us could ever dream of seeing already! And the right/optimal big pharma partner is a lot better suited to get the JadiCell one-of-a-kind solution all of humanity so desperately needs to the world ASAP...while simultaneously having the global mainstream media infrastructure already established to shout about the novel covid side of our JadiCell solution from rooftops all around the planet ok!
And if I'm right in my speculative musings based on the entire FACTUAL bread crumb trail TSOI and the FDA have unveiled to date...common sense alone dictates that this All Star team has the collective teamwork knowledge necessary to know that it makes much better sense to secure the big pharma collaborative partner 1st, then file however many EUA's they're planning on filing ok!
I'll gladly respond tomorrow if you still want/need any additional clarity from my personal perspective ok. I personally applaud our scientist CEO Tim Dixon for constantly educating us early joe retail investors to every query any s/h has ever posed to him...just to understand the covid side of JadiCell alone global potential involved...without even remotely factoring in Schizophrenia, COPD and CTE, with the novel CTE side of TSOI's novel JadiCell solution coming directly from the FDA themselves!
We are simply waiting for the big boy THUNDER coming, and trust me, it's going to be sending shockwaves throughout the entire OTC Market over the next full calendar year...the likes of which not a single joe retailer out there has even bothered to take the time to try to comprehend...because they only passively look at TSOI as a supposed penny stock, when nothing about TSOI is remotely close to a typical penny stock in any way shape or form at this amazing global launchpad juncture k cheers!
Never buy or sell based on my posts! My posts are just my opinion!
